Executing a successful remediation program: part 3 of 3

Published: 17-Mar-2025 Featured companies: NSF

Learn how NSF's Pharma Biotech experts help clients with remediation strategy, including FDA Warning Letters

The third part of this three-part series on executing an effective remediation program starts by looking at the importance of communication to the overall project. It also looks at, and answers, that age old question of ‘how long does a remediation project take to complete?’.

Read part one of the series here

Read part two of the series here

Click here to read about executing a successful remediation program (part 3)

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Manufacturing

Common reasons why field certifiers fail accreditation

Read more
Biosafety cabinets are the backbone of laboratory safety; however, many facilities encounter significant obstacles when using them, such as high energy consumption, difficulties with decontamination and inefficient filter replacement processes

Trending Articles

  1. Amgen pours $900m into US manufacturing capacity with Ohio expansion The biopharmaceutical company will expand the Ohio facility's operations and construct a second manufacturing plant in Holly Springs, North Carolina
  2. Optima strengthens Indian footprint with Pune site expansion The company will hire 40 engineering specialists to expand its presence in both the Indian and wider APAC market
  3. Guardtech Group Commercial Team ready to shine as jam-packed summer exhibition schedule hots up The Suffolk contamination control specialists are set to share their cleanroom construction products and services at shows covering Pharmaceuticals, Biotech, Chemical Process Engineering, Med-Tech, Battery Cells and more
  4. Roche to put $50bn into US manufacturing and R&D footprint The company will build new gene therapy, weight loss medication and continuous glucose monitoring manufacturing facilities situated across the US, as well as dedicated R&D centres
  5. PCI Pharma Serives acquires US-based sterile fill-finish CDMO, Ajinomoto Althea This acquisition will add antibody-drug conjugate (ADC) manufacturing and US-based sterile fill-finish production capabilities to PCI's portfolio

Relevant companies

See more

Upcoming event

Boosting Sustainability and Efficiency in Pharma Manufacturing

14 May 2025 | Virtual See all

You may also like

Manufacturing

Common reasons why field certifiers fail accreditation

Biosafety cabinets are the backbone of laboratory safety; however, many facilities encounter significant obstacles when using them, such as high energy consumption, difficulties with decontamination and inefficient filter replacement processes
Pharmaceutical

How to replace old mindsets with a quality mindset

Replace old mindsets with a quality focused mindset to get better results in pharma operations. How? Read this article to find out more
Regulatory

FDA US Agent Services, backed by former regulators and global expertise

If you need a trusted US Agent backed by regulatory experts, NSF can keep your US market entry on track
Training & Education

Unlock new career opportunities as a Qualified Person (QP) - learn how

Catherine Kay from NSF looks at the requirements that prospective QPs need to consider and what to expect from QP training with NSF
Pharmaceutical

How you can improve quality and efficiency with internal audits

This article looks at how your company can improve both quality and efficiency by conducting effective internal audits
Regulatory

How to handle regulatory authority warning letters

What should a company do when they receive a warning letter from the FDA? Find out in this article
Medical Devices

Why rigorous clinical evaluations matter: strategies to boost safety and compliance

This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements
Subscribe now